farnesol has been researched along with farnesylamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, KK; Chambers, AF; Guthrie, N; Kothapalli, R; Lui, EM | 1 |
| Carroll, KK; Chambers, AF; Guthrie, N; Kothapalli, R | 1 |
| kato, J; Kogo, Y | 1 |
| Fujii, T; Itoh, A; Kohgo, Y; Nishino, N; Obara, T; Shudo, R; Tanno, S; Ura, H | 1 |
| Habiro, A; Izawa, T; Kohgo, Y; Mizukami, Y; Obara, T; Osanai, M; Tanno, S; Ura, H; Yanagawa, N | 1 |
| Mizukami, Y | 1 |
| Clark, DA; Heterick, BE; Jones, TH; Snelling, RR | 1 |
| Bereta, G; Blaner, WS; Golczak, M; Hunzelmann, S; Kiser, PD; Maeda, A; Maeda, T; Palczewski, K; von Lintig, J | 1 |
1 review(s) available for farnesol and farnesylamine
| Article | Year |
|---|---|
[Malignant tumor and apoptosis].
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Apoptosis; Farnesol; Farnesyltranstransferase; Humans; Neoplasms; ras Proteins; Tumor Suppressor Protein p53 | 1997 |
7 other study(ies) available for farnesol and farnesylamine
| Article | Year |
|---|---|
Effects of long-chain fatty amines on the growth of ras-transformed NIH 3T3 cells.
Topics: 3T3 Cells; Amines; Animals; Calcium; Cell Division; Cell Line, Transformed; Farnesol; Fatty Acids; Genes, ras; Mice; Protein Kinase C | 1994 |
Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Cell Division; Cell Line, Transformed; Cholesterol; Dolichols; Farnesol; Farnesyltranstransferase; Mice; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Transferases; Ubiquinone | 1993 |
Selective cytotoxicity of farnesylamine to pancreatic carcinoma cells and Ki-ras-transformed fibroblasts.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Apoptosis; Cell Transformation, Neoplastic; DNA Fragmentation; Enzyme Inhibitors; Farnesol; Genes, ras; Mice; Pancreatic Neoplasms; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Signal Transduction | 1998 |
Requirement of c-jun N-terminal kinase for apoptotic cell death induced by farnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells.
Topics: Alkyl and Aryl Transferases; Amines; Antineoplastic Agents; Apoptosis; Enzyme Inhibitors; Farnesol; Farnesyltranstransferase; Genes, ras; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Mutation; Pancreatic Neoplasms; Tumor Cells, Cultured | 2001 |
[Oleylamine (long-chain fatty amine)-induced cell death through MAP kinase pathways in human pancreatic cancer cells].
Topics: Amines; Apoptosis; Enzyme Inhibitors; Farnesol; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Tumor Cells, Cultured | 2002 |
Farnesylamine from the ant Monomorium fieldi Forel.
Topics: Alkaloids; Amines; Animals; Ants; Australia; Farnesol; Gas Chromatography-Mass Spectrometry; Molecular Structure; Sesquiterpenes; Species Specificity; Stereoisomerism | 2003 |
Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina.
Topics: Absorption; Animals; Biological Transport; Carrier Proteins; cis-trans-Isomerases; Diterpenes; Enzyme Inhibitors; Eye Proteins; Farnesol; Mice; Mice, Knockout; NIH 3T3 Cells; Organ Specificity; Photoreceptor Cells, Vertebrate; Retinaldehyde; Rhodopsin; Vision Disorders; Vision, Ocular | 2008 |